Arkolith/Insider Trading/EGRX/Form 4

Tarriff Scott

CEO, Director, 10% OwnerEAGLE PHARMACEUTICALS, INC. (EGRX) · full profile →Form 4 · filed Mar 2, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 1, 2023Grant(A)71K—$01.6M
Feb 28, 2023Tax withholding(F)3K$28.00$87K1.6M

Transaction Codes

A
Grant / award
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-014646) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML